KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Depreciation & Amortization (CF): 2009-2024

Historic Depreciation & Amortization (CF) for Chemed (CHE) over the last 16 years, with FY2024 value amounting to $63.0 million.

  • Chemed's Depreciation & Amortization (CF) rose 342.1% to $16.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.3 million, marking a year-over-year increase of 252.56%. This contributed to the annual value of $63.0 million for FY2024, which is 358.83% up from last year.
  • Chemed's Depreciation & Amortization (CF) amounted to $63.0 million in FY2024, which was up 358.83% from $60.9 million recorded in FY2023.
  • In the past 5 years, Chemed's Depreciation & Amortization (CF) registered a high of $63.0 million during FY2024, and its lowest value of $56.6 million during FY2020.
  • Its 5-year average for Depreciation & Amortization (CF) is $59.7 million, with a median of $59.2 million in 2022.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first skyrocketed by 2516.98% in 2020, then rose by 20.49% in 2022.
  • Chemed's Depreciation & Amortization (CF) (Annual) stood at $56.6 million in 2020, then grew by 4.36% to $59.1 million in 2021, then rose by 0.2% to $59.2 million in 2022, then rose by 2.86% to $60.9 million in 2023, then rose by 3.59% to $63.0 million in 2024.
  • Its Depreciation & Amortization (CF) stands at $63.0 million for FY2024, versus $60.9 million for FY2023 and $59.2 million for FY2022.